about
Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVEAspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effectEffects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitorsLevosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized TrialBeta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart FailRandomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with thePhysiology of the abnormal response of heart failure patients to exercise.Effects of Cardiopulmonary Exercise Rehabilitation on Left Ventricular Mechanical Efficiency and Ventricular-Arterial Coupling in Patients With Systolic Heart FailureRelation between volume of exercise and clinical outcomes in patients with heart failure.Heart failure and diabetes mellitus: epidemiology and management of an alarming association.State of the art: using natriuretic peptide levels in clinical practice.Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.Methodological approach to the first and second lactate threshold in incremental cardiopulmonary exercise testing.Benefits of exercise training in chronic heart failure.Baseline subendocardial viability ratio influences left ventricular systolic improvement with cardiac rehabilitation.So many definitions of heart failure: are they all universally valid? A critical appraisal.Molecular mechanisms in evolutionary cardiology failure.Very early management of acute heart failure syndromes.Update on the medical treatment of stable angina.Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.Galectin-3 in heart failure with preserved ejection fraction.Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties.Physical activity: from epidemiological evidence to individualized patient management.Iron deficiency: an emerging therapeutic target in heart failure.Prognostic markers of acute decompensated heart failure: the emerging roles of cardiac biomarkers and prognostic scores.Effect of Ferric Carboxymaltose on Exercise Capacity in Patients with Chronic Heart Failure and Iron Deficiency.An education program for risk factor management after an acute coronary syndrome: a randomized clinical trial.Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.Management of acute heart failure in elderly patients.Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure.Towards Holistic Heart Failure Management-How to Tackle the Iron Deficiency Epidemic?Trends in death attributed to heart failure over the past two decades in Europe.Increasing awareness and perception of heart failure in Europe and improving care--rationale and design of the SHAPE Study.Loss of Notch3 Signaling in Vascular Smooth Muscle Cells Promotes Severe Heart Failure Upon Hypertension.Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry.Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure.Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort.Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure.
P50
Q24650903-0A8C804A-8222-44A8-BF4E-8496F39DB6FDQ28196412-B62DA2EF-A6C9-4582-BD68-08CB1FAB524DQ28200166-D8D8A313-0DB3-4C25-87F1-280894AD1A42Q28300233-DF359794-35FC-48FE-ACD8-93895EE6DD20Q33460799-4B069767-4EE8-4E02-941E-6BFA4961A582Q34383304-D39705B0-4AF6-4E2F-BCFA-7FF5D9BB37CDQ34565386-CC97C8B5-0E2A-4C6D-99FB-031991FC9152Q34830023-767B4537-D7A6-4B0D-8265-BA61C257447DQ35742256-12B27BE3-2229-4F23-A96C-CA231D5F8B14Q36835946-3B8006D1-ABAB-4979-BA1F-6F2C6FF12BB3Q37246414-F877C458-E838-4966-92DA-EC279B69180DQ37250235-74184D20-6CA5-4E7D-B36D-BA4EBBD23F82Q37257460-D877D368-B455-4560-89FD-C3FF4514E42FQ37312535-997C0629-71EE-4209-AB50-298EF7E658F2Q37339590-A1D806C0-4166-4E76-807A-7C8C81041F26Q37632928-8F7670E3-87A4-4A2B-94B4-512B8160D6DAQ37664491-8C35F647-5F37-404D-9839-E8FA90177B19Q37688161-91A27615-899E-40AF-B31E-76976ABEAA80Q37702396-EACCE579-12CA-4A38-B74E-03D73B899A5AQ37899708-5404F3CD-B9F6-4D42-9F88-781C99CF004CQ37951697-B5ECABC8-8312-479E-BAF0-24A7D231125AQ38040078-EC26EB8E-B58E-48E4-A92C-550BD2816453Q38104695-8B3C3DAF-F572-4FEF-8141-87A9102770D0Q38127568-3D01B4AE-2916-4D75-8CC7-D4C25B670B57Q38167403-70F36317-65FE-43FF-8C51-5C20F401CDBCQ38222610-4154779D-97E5-474F-AE98-32FB83B37F2FQ38298408-E9AB99E7-4399-4699-9022-2AA498336BBCQ38374099-87E73F45-44BD-4083-B382-6B9877903FC9Q38442963-83658397-DB64-4820-8131-B9575CDE538FQ38809793-0A6291C2-F5E2-4071-8BC0-5A02E67696CBQ38835768-95CC0FE9-6F78-4885-A3BF-7F5F90329AEAQ38868193-68E6CD39-AF37-427B-9CA6-5F11CC9D821BQ39409288-4CCB5426-BB18-49DC-A6F7-1C628D59BFA7Q39665398-1EA2F9BE-46B1-4238-9A6F-9044CB0434D6Q39685832-78D842E4-37B5-48C0-B1DF-0E0C028BEA1AQ39686607-4B3DB89A-A20C-4B49-B5BA-4B6D57B5455BQ40478267-9FD96C01-4A26-46E4-8706-C7A94F00BC80Q40482391-0FC66347-BC5C-4ADF-A38F-4CFCC7EFF870Q40485446-3B938700-669D-47E0-A7E1-B61CD0116345Q40697463-78729F20-F3CC-40B7-99DA-02F7A74D8BAE
P50
name
Alain Cohen-Solal
@ast
Alain Cohen-Solal
@en
Alain Cohen-Solal
@es
Alain Cohen-Solal
@nl
Alain Cohen-Solal
@sq
type
label
Alain Cohen-Solal
@ast
Alain Cohen-Solal
@en
Alain Cohen-Solal
@es
Alain Cohen-Solal
@nl
Alain Cohen-Solal
@sq
prefLabel
Alain Cohen-Solal
@ast
Alain Cohen-Solal
@en
Alain Cohen-Solal
@es
Alain Cohen-Solal
@nl
Alain Cohen-Solal
@sq
P214
P21
P214
P31
P735
P7859
viaf-166551922